From Health Canada:
Upon review of the available safety information, including reported cases of severe liver injury, Health Canada has determined that the benefit-risk profile for KETEK® no longer supports its use for the treatment of acute exacerbation of chronic bronchitis (AECB), acute bacterial sinusitis (ABS) or tonsillitis/pharyngitis. These indications will be removed from the label.
For health care professionals
For the public
Showing posts with label telithromycin. Show all posts
Showing posts with label telithromycin. Show all posts
Thursday, September 06, 2007
Wednesday, May 09, 2007
Sinus drug linked to liver damage, skin peeling
From the Vancouver Sun:
Somewhere near Quebec City lives a young mother who spent four weeks in a burn unit last year after a suspected drug reaction covered her body with burn-like red blisters and peeled off her skin from head to thigh.
The woman had been prescribed the antibiotic Ketek for a simple sinus infection.
But the 26-year-old developed toxic epidermal necrolysis, an extremely rare drug reaction where people essentially shed the outer protective layer of their skin. ...more
Somewhere near Quebec City lives a young mother who spent four weeks in a burn unit last year after a suspected drug reaction covered her body with burn-like red blisters and peeled off her skin from head to thigh.
The woman had been prescribed the antibiotic Ketek for a simple sinus infection.
But the 26-year-old developed toxic epidermal necrolysis, an extremely rare drug reaction where people essentially shed the outer protective layer of their skin. ...more
Subscribe to:
Posts (Atom)
